Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01 Clinical Trial Optional) | PA 18 274

Opportunity Information: Apply for PA 18 274

The National Institutes of Health (NIH) funding opportunity titled "Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01 Clinical Trial Optional)" (Funding Opportunity Number: PA-18-274) supports research that connects mental health with real-world HIV prevention and treatment outcomes. The overall aim is to strengthen the evidence base for how mental health conditions and related psychosocial factors shape behaviors and health outcomes across the full HIV care continuum, and then use that knowledge to build or improve interventions that can measurably improve both mental health and HIV-related endpoints.

This announcement emphasizes two main research directions. First, it encourages studies that advance understanding of the mechanisms through which mental health influences HIV prevention and treatment. In practice, that means identifying how mental health symptoms, diagnoses, stress processes, trauma exposure, substance use comorbidity, cognitive and emotional factors, social support, stigma, or structural barriers may drive outcomes such as HIV testing, prevention uptake, linkage to care, retention in care, medication adherence, and viral suppression. The key point is the focus on mechanisms that are modifiable, meaning they can realistically be targeted by an intervention, program change, or clinical strategy. Second, it encourages the development and testing of expanded interventions designed to improve mental health and HIV outcomes together, rather than treating them as separate issues. The intent is to support approaches that can move the needle on HIV prevention and treatment milestones while also improving psychological well-being, symptom burden, functioning, or related mental health outcomes.

The scope explicitly covers the entire HIV continuum, from HIV testing through sustained viral suppression. That broad framing allows applicants to propose work at any stage where mental health may be a barrier or leverage point, including earlier prevention-oriented steps (such as testing, risk reduction, or prevention engagement) and later care-oriented steps (such as retention, adherence, and sustained suppression). The "clinical trial optional" designation signals that applicants may propose either clinical trials or non-trial research designs, depending on what best fits the scientific question and stage of evidence development.

The FOA is part of a paired set of announcements that uses different NIH research project mechanisms depending on the maturity and risk profile of the work. The R01 mechanism is positioned for projects that already have preliminary data and/or propose more extensive and rigorous study designs, including longitudinal analyses, to test hypotheses about mechanisms or to evaluate interventions with stronger evidentiary support. In contrast, the companion R21 announcement (referenced as PA-17-137 in the description) is framed as more suitable for high-risk, high-reward projects, including early-stage ideas that may not yet have preliminary data or projects that primarily leverage existing datasets. In other words, the NIH is signaling flexibility: early exploratory work can fit the R21 path, while more developed programs of research with a stronger empirical foundation can fit the R01 route.

Eligibility is broad and includes many organizational types that might be positioned to conduct HIV and mental health research, implement interventions, or partner with affected communities. Eligible applicants listed include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding higher education institutions in those categories); for-profit organizations (other than small businesses); and small businesses. The announcement also highlights additional eligible applicant categories that reflect a strong interest in community reach and diversity of institutional participation, including faith-based and community-based organizations; Historically Black Colleges and Universities (HBCUs); Hispanic-serving Institutions; Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); eligible federal agencies; regional organizations; US territories or possessions; and non-domestic (non-US) entities/foreign organizations. That range suggests NIH is open to applications from both traditional academic research centers and organizations closely embedded in the communities most impacted by HIV and mental health inequities.

From the administrative details provided, this is a discretionary grant funding opportunity under NIH, with activity categories listed as education and health. The CFDA numbers associated with the opportunity are 93.242 and 93.279. The original closing date shown is January 7, 2020, and the record creation date is November 29, 2017. The award ceiling and expected number of awards are not specified in the provided source data, which typically means applicants should consult NIH budget guidance for the relevant mechanism and institute/center policies when planning project scope and costs.

Overall, the announcement is geared toward research that does more than document that mental health matters for HIV outcomes. It pushes applicants to explain why and how it matters (mechanisms), identify targets that can be changed (modifiable pathways), and then translate that into interventions that improve both mental health and HIV prevention/treatment outcomes across the full continuum of care.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.279.
• This funding opportunity was created on 2017-11-29.
• Applicants must submit their applications by 2020-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PA 18 274

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: